214 related articles for article (PubMed ID: 27203743)
21. A Potent HER3 Monoclonal Antibody That Blocks Both Ligand-Dependent and -Independent Activities: Differential Impacts of PTEN Status on Tumor Response.
Xiao Z; Carrasco RA; Schifferli K; Kinneer K; Tammali R; Chen H; Rothstein R; Wetzel L; Yang C; Chowdhury P; Tsui P; Steiner P; Jallal B; Herbst R; Hollingsworth RE; Tice DA
Mol Cancer Ther; 2016 Apr; 15(4):689-701. PubMed ID: 26880266
[TBL] [Abstract][Full Text] [Related]
22. Ubiquitin-ligase AIP4 controls differential ubiquitination and stability of isoforms of the scaffold protein ITSN1.
Dergai O; Dergai M; Rynditch A
FEBS Lett; 2018 Jul; 592(13):2259-2267. PubMed ID: 29851086
[TBL] [Abstract][Full Text] [Related]
23. Ubiquitin-mediated fluorescence complementation reveals that Jun ubiquitinated by Itch/AIP4 is localized to lysosomes.
Fang D; Kerppola TK
Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14782-7. PubMed ID: 15469925
[TBL] [Abstract][Full Text] [Related]
24. The E3 ubiquitin ligase atrophin interacting protein 4 binds directly to the chemokine receptor CXCR4 via a novel WW domain-mediated interaction.
Bhandari D; Robia SL; Marchese A
Mol Biol Cell; 2009 Mar; 20(5):1324-39. PubMed ID: 19116316
[TBL] [Abstract][Full Text] [Related]
25. CypA Regulates AIP4-Mediated M1 Ubiquitination of Influenza A Virus.
Mahesutihan M; Zheng W; Cui L; Li Y; Jiao P; Yang W; Liu W; Li J; Fan W; Yang L; Liu W; Sun L
Virol Sin; 2018 Oct; 33(5):440-448. PubMed ID: 30328013
[TBL] [Abstract][Full Text] [Related]
26. AIP4 restricts transforming growth factor-beta signaling through a ubiquitination-independent mechanism.
Lallemand F; Seo SR; Ferrand N; Pessah M; L'Hoste S; Rawadi G; Roman-Roman S; Camonis J; Atfi A
J Biol Chem; 2005 Jul; 280(30):27645-53. PubMed ID: 15946939
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation of the E3 ubiquitin protein ligase ITCH diminishes binding to its cognate E2 ubiquitin ligase.
Perez JM; Chen Y; Xiao TS; Abbott DW
J Biol Chem; 2018 Jan; 293(3):1100-1105. PubMed ID: 29212706
[TBL] [Abstract][Full Text] [Related]
28. Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1.
Cao Z; Wu X; Yen L; Sweeney C; Carraway KL
Mol Cell Biol; 2007 Mar; 27(6):2180-8. PubMed ID: 17210635
[TBL] [Abstract][Full Text] [Related]
29. Atrophin-1-interacting protein 4/human Itch is a ubiquitin E3 ligase for human enhancer of filamentation 1 in transforming growth factor-beta signaling pathways.
Feng L; Guedes S; Wang T
J Biol Chem; 2004 Jul; 279(28):29681-90. PubMed ID: 15051726
[TBL] [Abstract][Full Text] [Related]
30. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
[TBL] [Abstract][Full Text] [Related]
31. Reciprocal regulation of the ubiquitin ligase Itch and the epidermal growth factor receptor signaling.
Azakir BA; Angers A
Cell Signal; 2009 Aug; 21(8):1326-36. PubMed ID: 19341794
[TBL] [Abstract][Full Text] [Related]
32. ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells.
Choi BK; Fan X; Deng H; Zhang N; An Z
Cancer Med; 2012 Aug; 1(1):28-38. PubMed ID: 23342251
[TBL] [Abstract][Full Text] [Related]
33. Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib.
Servidei T; Riccardi A; Mozzetti S; Ferlini C; Riccardi R
Int J Cancer; 2008 Dec; 123(12):2939-49. PubMed ID: 18803287
[TBL] [Abstract][Full Text] [Related]
34. The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein-coupled receptor CXCR4.
Marchese A; Raiborg C; Santini F; Keen JH; Stenmark H; Benovic JL
Dev Cell; 2003 Nov; 5(5):709-22. PubMed ID: 14602072
[TBL] [Abstract][Full Text] [Related]
35. Itch/AIP4 mediates Deltex degradation through the formation of K29-linked polyubiquitin chains.
Chastagner P; Israël A; Brou C
EMBO Rep; 2006 Nov; 7(11):1147-53. PubMed ID: 17028573
[TBL] [Abstract][Full Text] [Related]
36. The E3 ubiquitin ligase Itch regulates tumor suppressor protein RASSF5/NORE1 stability in an acetylation-dependent manner.
Suryaraja R; Anitha M; Anbarasu K; Kumari G; Mahalingam S
Cell Death Dis; 2013 Mar; 4(3):e565. PubMed ID: 23538446
[TBL] [Abstract][Full Text] [Related]
37. Amot130 adapts atrophin-1 interacting protein 4 to inhibit yes-associated protein signaling and cell growth.
Adler JJ; Heller BL; Bringman LR; Ranahan WP; Cocklin RR; Goebl MG; Oh M; Lim HS; Ingham RJ; Wells CD
J Biol Chem; 2013 May; 288(21):15181-93. PubMed ID: 23564455
[TBL] [Abstract][Full Text] [Related]
38. Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change.
Gallagher E; Gao M; Liu YC; Karin M
Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1717-22. PubMed ID: 16446428
[TBL] [Abstract][Full Text] [Related]
39. The E3 ubiquitin ligase Itch and Yap1 have antagonistic roles in the regulation of ASPP2 protein stability.
Gao K; An J; Zhang Y; Jin X; Ma J; Peng J; Tang Y; Yu L; Zhang P; Wang C
FEBS Lett; 2015 Jan; 589(1):94-101. PubMed ID: 25436413
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.
Desbois-Mouthon C; Baron A; Blivet-Van Eggelpoël MJ; Fartoux L; Venot C; Bladt F; Housset C; Rosmorduc O
Clin Cancer Res; 2009 Sep; 15(17):5445-56. PubMed ID: 19706799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
